Trial Profile
A Phase I Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) Administered Daily x 5 in Combination With Cisplatin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs OCX 191 (Primary) ; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Vion Pharmaceuticals
- 08 Jul 2017 New trial record